Newsfilter article unlocker

Enter Newsfilter article ID in the field below.
Example: https://newsfilter.io/articles/39be1bef03e66cdc886c08a2a6319c47

Retrieved article

GoHealth, Inc. (NASDAQ:GOCO) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET

Company Participants

John E. Shave - Vice President of Investor Relations
Vijay Kumar Kotte - CEO & Director

Conference Call Participants

David Joseph Storms - Stonegate Capital Partners, Inc., Research Division
Ilya Zubkov - Freedom Broker, Research Division
James Philip Sidoti - Sidoti & Company, LLC
Patrick Joseph McCann - NOBLE Capital Markets, Inc., Research Division
Robert Miles McGuire - Granite Research, LLC

Operator

Good day, and welcome to the GoHealth Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.

I would now like to turn the conference call over to John Shave, Vice President of Investor Relations. Please go ahead.

John E. Shave

Thank you, and good morning. Welcome to GoHealth's Second Quarter 2025 Results Call. Joining me today are Vijay Kotte, Chief Executive Officer; and Brendan Shanahan, Chief Financial Officer.

Today's conference call contains forward-looking statements based on our current expectations. Numerous known and unknown risks and uncertainties may cause actual results to differ materially from those anticipated or projected in these statements. Many of the factors that will determine future results are beyond the company's ability to control or predict. You should not place undue reliance on any forward-looking statements, and the company undertakes no obligation to update or revise any of these statements, whether due to new information, future events or otherwise.

Earlier today, we issued a press release announcing a series of strategic capital and governance actions that significantly enhance GoHealth's financial flexibility and long-term positioning as well as our results for the second quarter 2025. We have posted the release on the GoHealth website under the Investor Relations tab.

In the press release, we have listed certain risk factors that you should consider in conjunction


...